Patients, families and caregivers are invited to attend an educational conference covering many aspects of brain tumors May 14 at Cedars-Sinai Medical Center. The free, Saturday program, "Outsmarting Brain Tumors," will feature presentations by Keith L. Black, MD, chairman of the Department of Neurosurgery, and other treatment and research experts...

Generating real-world data through late phase clinical and observational studies to achieve clinical, pharmacovigilance and marketing objectives 3 EVENTS IN ONE: Late Phase Leaders Forum (2 days) Comparative Effectiveness Research Leaders Day (1 day) Late Phase Research for Medical Devices (1 day) Day 1&2: October 8th & ...

Drug development strategies for indication expansion and lifecycle extension 11 - 13 September 2012, Jumeirah Carlton Tower, London, UK As the cost and time of drug development persistently increases, drug repositioning is becoming an increasingly important strategy for large pharma and small biotech alike to successfully innovate in a ...

Strategies for navigating the regulatory, manufacturing, sales and marketing route to biosimilar market entry. 11 - 13 September 2012, Jumeirah Carlton Tower, London, UK Get competitive insight into global regulatory strategies, and find out how to successfully bring biosimilars to-market in developed and developing regions...

There is a great deal of unmet need in the effective treatment of numerous types of cancer, as long-term survival rates are still rather poor for a number of cancers. There is a strong need for more effective therapies that will extend survival, with potential for new immunostimulatory therapies ...

Biosimilar development costs are high with some industry leaders claiming estimates of $100-150 million. Even after this substantial investment there is no guarantee of immediate return. With the FDA, America's regulatory body, struggling to agree on a suitable approval pathway for biosimilars to reach market in the U.S. and similar ...

Why Should You Attend? 3rd Annual Pharmacovigilance 2012 - "Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management" Get more from the event, with a broader scope bringing the whole communications value chain to gather. Enjoy and make the best out of our ...

New directions in drug discovery and development Biomarkers World Europe has established itself as the premier European event for biomarker development and implementation from discovery through to personalized medicine. Create an optimum biomarker strategy and be able to move towards personalised therapeutics with the insight of the world's leading biomarker ...